Healthcare -
Biotechnology - NASDAQ - US
$ 45.74
-2.66 %
$ 5.4 B
Market Cap
-8.5
P/E
Price Target
Average
102.23%
Revenue Forecast
Estimate
448.66%
EBIT
Estimate
--35.84%
Net Income
Estimate
36.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cytokinetics, Incorporated
Wall Street analysts predict an average 1-year price target for CYTK of $92.5 , with forecasts ranging from
a
low of
$60 to a high of $120 .
CYTK Lowest Price Target
Wall Street Target
60 USD
31.18%
CYTK Average Price Target
Wall Street Target
92.5 USD
102.23%
CYTK Highest Price Target
Wall Street Target
120 USD
162.35%
REVENUE FORECAST
Revenue Forecast Chart CYTK
EBIT FORECAST
EBIT Forecast Chart CYTK
NET INCOME FORECAST
Net Income Chart CYTK